Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of extended-release hydrocodone/acetaminophen tablets for postoperative moderate to severe pain
CTR20240715Phase 3Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain and pain comparing Hydrocodone/acetaminophen extended-release with Placebo (2 arms). Primary endpoint: SPID48. Started Nov 2024; status: active.
02
Drugs
hydrocodone bitartrate + acetaminophen
03
Conditions
postoperative painpain
Beyond the preview
Go deeper on CTR20240715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240715.